Cargando…

Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer

Long-term cardiovascular morbidity is increasingly observed in chemotherapy-treated testicular cancer survivors, but little is known of early sub-clinical changes in cardiac function. We prospectively evaluated cardiac function in testicular cancer patients by echocardiography. Systolic (Wall Motion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altena, R, de Haas, E C, Nuver, J, Brouwer, C A J, van den Berg, M P, Smit, A J, Postma, A, Sleijfer, D Th, Gietema, J A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714243/ https://www.ncbi.nlm.nih.gov/pubmed/19455138 http://dx.doi.org/10.1038/sj.bjc.6605095

Ejemplares similares

Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors
por: Boer, H., et al.
Publicado: (2015)

Shared-care survivorship program for testicular cancer patients: safe and feasible
por: Boer, H., et al.
Publicado: (2022)

Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy
por: Shields, Lisa B E, et al.
Publicado: (2021)

Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy
por: Stelwagen, Johannes, et al.
Publicado: (2020)

Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage
por: Altena, Renske, et al.
Publicado: (2015)

Chemotherapy for testicular cancer induces acute alterations in diastolic heart function
por: van Schinkel, L D, et al.
Publicado: (2013)

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
por: Turner, N C, et al.
Publicado: (2010)

Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapy
por: Tuinman, Marrit A., et al.
Publicado: (2006)

Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life
por: Lubberts, Sjoukje, et al.
Publicado: (2023)

Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function—an exploratory analysis
por: van der Schoot, Gabriela G. F., et al.
Publicado: (2023)

Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer
por: Cameron, Alan C., et al.
Publicado: (2020)

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
por: Willemse, P M, et al.
Publicado: (2013)

The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up
por: Bjerring, Anders W, et al.
Publicado: (2020)

Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway
por: Koster, R, et al.
Publicado: (2011)

Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
por: Oh, S C, et al.
Publicado: (2005)

Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy
por: Han, K S, et al.
Publicado: (2008)

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
por: Bokemeyer, C., et al.
Publicado: (1998)

Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients
por: Garcia, Sara L, et al.
Publicado: (2020)

Geographic clustering of testicular cancer incidence in the northern part of The Netherlands
por: Sonneveld, D J A, et al.
Publicado: (1999)

How to Manage Cisplatin-Based Chemotherapy–Related Cardiovascular Disease in Patients With Testicular Cancer
por: Kadambi, Sindhuja, et al.
Publicado: (2022)

Risk of diabetes after para-aortic radiation for testicular cancer
por: Groot, Harmke J., et al.
Publicado: (2018)

Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)
por: Nicholson, S, et al.
Publicado: (2013)

Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy
por: Steggink, Lars C., et al.
Publicado: (2020)

Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy
por: Garcia, Sara L., et al.
Publicado: (2023)

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma
por: Starling, N, et al.
Publicado: (2009)

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma
por: Sørensen, J B, et al.
Publicado: (2008)

Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer
por: Kim, S T, et al.
Publicado: (2005)

Reply: Comment on ‘Chemotherapy for testicular cancer induces acute alterations in diastolic heart function'
por: van Schinkel, L D, et al.
Publicado: (2014)

Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program
por: Paken, J., et al.
Publicado: (2017)

Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer
por: Dassen, Anneriet E, et al.
Publicado: (2016)

Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
por: Fung, Chunkit, et al.
Publicado: (2018)

Advantages in Combination Chemotherapy Using Cisplatin and Its Analogues for Human Testicular Tumor Xenografts
por: Hida, Shuichi, et al.
Publicado: (1990)

Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.
por: Hilkens, P. H., et al.
Publicado: (1997)

Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment
por: Stelwagen, Johannes, et al.
Publicado: (2021)

Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
por: Broekman, K. Esther, et al.
Publicado: (2020)

Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study
por: Wilkowski, R, et al.
Publicado: (2009)

Associations of Body Fat Distribution and Cardiometabolic Risk of Testicular Cancer Survivors After Cisplatin-Based Chemotherapy
por: Wibmer, Andreas G, et al.
Publicado: (2022)

Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect.
por: Sleijfer, S., et al.
Publicado: (1995)

Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors
por: Singh, Ratnakar, et al.
Publicado: (2019)

Thrombosis of abdominal aorta during cisplatin-based chemotherapy of testicular seminoma - a case report
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_vv9111t5enrl4og00lnm3hu8bb